Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
CSL projects a return to growth for plasma unit Behring
After impairments, downgrades and the ousting of its CEO, CSL has flashed signs of recovery, projecting growth for its plasma unit CSL Behring.
Kevin Dunleavy
Aug 18, 2026 11:35am
Biokin, BMS' bispecific ADC hits goal in China lung cancer trial
Aug 18, 2026 11:18am
Valeris taps new strategy chief in patient services vet
Aug 18, 2026 10:51am
CMI adopts orphan drug field with dedicated center of excellence
Aug 18, 2026 10:11am
Celcuity needs facility sign-off to kick off its market launch
Aug 18, 2026 9:26am
EyePoint phase 3 for AMD disappoints, tanking stock
Aug 17, 2026 3:30pm
More News
Quanovate scratches marketing claims for Mira fertility wand
Aug 17, 2026 2:50pm
Sanofi cuts 229 Blueprint jobs, closes Cambridge sites
Aug 17, 2026 2:41pm
AstraZeneca dual lung cancer wins softened by bispecific fail
Aug 17, 2026 10:56am
Argenx preps next potential Vyvgart nod after ph. 3 win
Aug 17, 2026 10:52am
